Literature DB >> 31904839

Opioid Prescribing to Medicare Part D Enrollees, 2013-2017: Shifting Responsibility to Pain Management Providers.

Adam N Romman1, Connie M Hsu2, Lin-Na Chou3, Yong-Fang Kuo3,4, Rene Przkora5, Rajnish K Gupta6, M James Lozada6.   

Abstract

OBJECTIVE: To examine opioid prescribing frequency and trends to Medicare Part D enrollees from 2013 to 2017 by medical specialty and provider type.
METHODS: We conducted a retrospective, cross-sectional, specialty- and provider-level analysis of Medicare Part D prescriber data for opioid claims from 2013 to 2017. We analyzed opioid claims and prescribing trends for specialties accounting for ≥1% of all opioid claims.
RESULTS: From 2013 to 2017, pain management providers increased Medicare Part D opioid claims by 27.3% to 1,140 mean claims per provider in 2017; physical medicine and rehabilitation providers increased opioid claims 16.9% to 511 mean claims per provider in 2017. Every other medical specialty decreased opioid claims over this period, with emergency medicine (-19.9%) and orthopedic surgery (-16.0%) dropping opioid claims more than any specialty. Physicians overall decreased opioid claims per provider by -5.2%. Meanwhile, opioid claims among both dentists (+5.6%) and nonphysician providers (+10.2%) increased during this period.
CONCLUSIONS: From 2013 to 2017, pain management and PMR increased opioid claims to Medicare Part D enrollees, whereas physicians in every other specialty decreased opioid prescribing. Dentists and nonphysician providers also increased opioid prescribing. Overall, opioid claims to Medicare Part D enrollees decreased and continue to drop at faster rates.
© 2020 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Analgesic; Chronic Pain; Narcotics; Opioids; Pain Management; Prescriptions

Mesh:

Substances:

Year:  2020        PMID: 31904839      PMCID: PMC7820360          DOI: 10.1093/pm/pnz344

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.637


  27 in total

1.  Distribution of Opioids by Different Types of Medicare Prescribers.

Authors:  Jonathan H Chen; Keith Humphreys; Nigam H Shah; Anna Lembke
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

2.  Differences in Opioid Prescribing Among Generalist Physicians, Nurse Practitioners, and Physician Assistants.

Authors:  Michael I Ellenbogen; Jodi B Segal
Journal:  Pain Med       Date:  2020-01-01       Impact factor: 3.750

3.  Limits on Opioid Prescribing Leave Patients With Chronic Pain Vulnerable.

Authors:  Rita Rubin
Journal:  JAMA       Date:  2019-06-04       Impact factor: 56.272

4.  Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study.

Authors:  S C Brighthaupt; E M Stone; L Rutkow; E E McGinty
Journal:  Prev Med       Date:  2019-05-29       Impact factor: 4.018

5.  Physician Dispensing of Oxycodone and Other Commonly Used Opioids, 2000-2015, United States.

Authors:  Karin Ann Mack; Christopher McCall Jones; Roderick John McClure
Journal:  Pain Med       Date:  2018-05-01       Impact factor: 3.750

6.  Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic.

Authors:  Allison L Pitt; Keith Humphreys; Margaret L Brandeau
Journal:  Am J Public Health       Date:  2018-08-23       Impact factor: 9.308

7.  No Shortcuts to Safer Opioid Prescribing.

Authors:  Deborah Dowell; Tamara Haegerich; Roger Chou
Journal:  N Engl J Med       Date:  2019-04-24       Impact factor: 91.245

8.  Assessment of Changes in the Geographical Distribution of Opioid-Related Mortality Across the United States by Opioid Type, 1999-2016.

Authors:  Mathew V Kiang; Sanjay Basu; Jarvis Chen; Monica J Alexander
Journal:  JAMA Netw Open       Date:  2019-02-01

9.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586

10.  Evidence for state, community and systems-level prevention strategies to address the opioid crisis.

Authors:  Tamara M Haegerich; Christopher M Jones; Pierre-Olivier Cote; Amber Robinson; Lindsey Ross
Journal:  Drug Alcohol Depend       Date:  2019-09-19       Impact factor: 4.852

View more
  5 in total

1.  Social isolation, residential stability, and opioid use disorder among older Medicare beneficiaries: Metropolitan and non-metropolitan county comparison.

Authors:  Tse-Chuan Yang; Carla Shoff; Seulki Kim
Journal:  Soc Sci Med       Date:  2021-11-25       Impact factor: 4.634

2.  Opioid-Free Discharge is Not Associated With Increased Unplanned Healthcare Encounters After Ureteroscopy: Results From a Statewide Quality Improvement Collaborative.

Authors:  Scott R Hawken; Spencer C Hiller; Stephanie Daignault-Newton; Khurshid R Ghani; John M Hollingsworth; Bronson Conrado; Conrad Maitland; David L Wenzler; John K Ludlow; Sapan N Ambani; Chad M Brummett; Casey A Dauw
Journal:  Urology       Date:  2021-09-01       Impact factor: 2.649

3.  Opioid Prescribing by Primary Care Providers: a Cross-Sectional Analysis of Nurse Practitioner, Physician Assistant, and Physician Prescribing Patterns.

Authors:  M James Lozada; Mukaila A Raji; James S Goodwin; Yong-Fang Kuo
Journal:  J Gen Intern Med       Date:  2020-04-24       Impact factor: 5.128

4.  State Variation in Chronic Opioid Use in Long-Term Care Nursing Home Residents.

Authors:  Hemalkumar B Mehta; Yong-Fang Kuo; Mukaila A Raji; Jordan Westra; Cynthia Boyd; G Caleb Alexander; James S Goodwin
Journal:  J Am Med Dir Assoc       Date:  2021-05-19       Impact factor: 4.669

5.  Opioid Prescriptions by Pain Medicine Physicians in the Medicare Part D Program: A Cross-Sectional Study.

Authors:  Vasudha Goel; Benedict Moran; Alexander M Kaizer; Eellan Sivanesan; Amol M Patwardhan; Mohab Ibrahim; Jacob C DeWeerth; Clarence Shannon; Hariharan Shankar
Journal:  Anesth Analg       Date:  2021-06-01       Impact factor: 6.627

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.